Ecofy

Your Chief AI Officer · Monday, October 26, 2026 · Act today

Dana-Farber names first chief AI officer as Cleveland Clinic forms AI office

Announced2 sourcesFor patients and employees

Dana-Farber Cancer Institute named Eliezer Van Allen, MD, its inaugural chief AI officer to lead AI strategy, governance and portfolio across research, clinical, operational and administrative work, Becker's reported. Cleveland Clinic Cancer Institute set up an Office of Technology and Digital Strategy, led by oncologists Paul Thambi, MD, and Louis Williams, MD, to evaluate AI tools and streamline adoption, per an Oct. 26 release reported by Becker's.

Two of the country's best-known cancer programs have put a named owner on artificial intelligence. Boston-based Dana-Farber Cancer Institute named Eliezer Van Allen, MD, its inaugural chief AI officer, the cancer center said in an Oct. 23 LinkedIn post, Becker's reported. Dr. Van Allen will lead AI strategy, governance and portfolio across research, clinical, operational and administrative work, with responsibilities that include AI platform development and implementation. Separately, Cleveland Clinic Cancer Institute established a task force, the Cancer Institute Office of Technology and Digital Strategy, to evaluate AI tools and streamline their adoption into operations and clinical care. It is led by oncologists Paul Thambi, MD, and Louis Williams, MD, according to an Oct. 26 news release reported by Becker's.

The two models differ in a way boards should notice. Dana-Farber placed AI under a single executive whose remit spans the whole enterprise, from the lab to the back office. Cleveland Clinic's cancer institute built an office led by practicing oncologists, putting tool evaluation close to the clinicians who will use it. Both approaches answer the same problem: AI tools are arriving faster than most organizations can vet them, and without a clear owner, decisions about clinical use, administrative automation, data access and vendor risk scatter across departments.

The claim from both organizations is that a dedicated leader or office will speed safe adoption. The evidence is limited to the announcements themselves. No outcome data exists yet on whether these structures shorten evaluation cycles, reduce administrative burden on staff or improve care, so leaders should treat them as organizational choices worth watching rather than proven results.

The move is to decide this week who in your organization owns AI governance end to end, and give that person a written mandate covering both clinical and administrative use. The mandate should state who approves new tools, how clinicians are involved in evaluation, how security and privacy review fit into that approval, and what the owner reports to the CEO and board. A named owner with clear authority gives physicians a single place to bring requests, gives compliance and security teams a consistent review path, and gives the board one accountable answer when it asks where AI is being used and why.

Do this week. Decide this week who in your organization owns AI governance end to end, and give that person a written mandate covering clinical and administrative use.

Run this

The prompt to act on this item, for your own model.

Paste it into Claude, ChatGPT or Copilot and fill the bracketed slots with your own numbers. The output is a draft for your team to check, built only from the sources on this page. Never paste patient data.

You are an operations advisor to the CEO and board of [your organization], a [type of organization, such as health system, physician group or wellness network].

Context: Two cancer programs have put a named owner on AI. Dana-Farber Cancer Institute named Eliezer Van Allen, MD, its inaugural chief AI officer, per an Oct. 23 LinkedIn post, to lead AI strategy, governance and portfolio across research, clinical, operational and administrative work, as reported by Becker's Hospital Review. Cleveland Clinic Cancer Institute established the Cancer Institute Office of Technology and Digital Strategy, led by oncologists Paul Thambi, MD, and Louis Williams, MD, to evaluate AI tools and streamline their adoption into operations and clinical care, per an Oct. 26 news release reported by Becker's Hospital Review. Both organizations say a dedicated leader or office will speed safe adoption. These are organizational announcements, and no outcome data exists yet.

Task: Help us decide this week who in our organization owns AI governance end to end, and draft a written mandate for that person covering both clinical and administrative use. Weigh the two models, a single enterprise executive versus a clinician-led office, against our situation.

Output: a one-page memo for the executive team with these sections: Recommendation, Options Considered, Draft Mandate (who approves new tools, how clinicians are involved in evaluation, how security and privacy review fit into approval, and what the owner reports to the CEO and board), Open Questions, and Steps to Finish This Week.

Our details: [candidate owner name and title], [number of AI tools currently in use or under review], [committees or departments that currently review AI or technology requests], [date of next board meeting].

Guardrails: Use only the facts above and the details I fill in. Cite sources by name, Becker's Hospital Review. Flag anything uncertain or that needs verifying, and do not present these structures as proven results. Do not request or include any patient data. Nothing here is medical advice. Label the memo as a draft for the team to check.

Open in ClaudeOpen in ChatGPT

The claim.
Both organizations say a dedicated leader or office will speed safe adoption of AI tools.
The evidence.
These are organizational announcements; no outcome data exists yet.

By seat

For the Chief AI Officer. Compare your charter with Dana-Farber's scope of strategy, governance and portfolio and close gaps.

For the CEO and board. Expect the board to ask who owns AI; name the role and its reporting line.

For the Chief Medical Officer and physicians. Consider physician co-leadership of AI evaluation, as Cleveland Clinic did with two oncologists.

Checked before publishing. 3 independent outlets. Also reported by Becker's Healthcare, Industry Dive.

Sources

  1. Becker's Hospital Review, Dana-Farber names 1st chief AI officer
  2. Becker's Hospital Review, Cleveland Clinic Cancer Institute establishes AI task force

Drafted by Lumen from the sources above, scored by a second pass on six criteria, then checked by rule against those sources (every figure, two independent outlets or a primary source) and published only when it passes. A person can pull any item, and corrections are published here. Apolitical, always. Nothing here is medical advice. How Your Chief AI Officer is made.

Also in this brief

Your Chief AI Officer

What AI and robotics can do for your organization today, and what is coming in thirty days.

Every weekday morning, ordered for your role. Free.

One click to confirm, one click to leave, and you can change your role or cadence any time. Your address stays with Ecofy and is never shared with sponsors or partners.